User Fee Management In CDER Plans To Enhance IT Capabilities
This article was originally published in The Tan Sheet
Executive Summary
The need to assimilate biosimilar and generic drug user fee programs and a quest for greater efficiency are major drivers of the center’s proposed $88.9 million spending plan on information technology systems in fiscal year 2014.
You may also be interested in...
New Food And Drug User Fees Face Long Odds In Congress
FDA’s $4.7 billion fiscal 2014 budget request proposes new fees including $58.9 million from food establishment registrations and inspections, $19.1 million from cosmetics firms and $15.04 million from medical product reinspections.
FDA’s IT Overhaul Stagnating Despite Massive Spending, GAO Finds
The agency has not been able to get rid of outdated IT systems despite spending more than $160 million to date on a program designed to do that among other goals.
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.